These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 26317552

  • 1. MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN.
    Yu T, Liu L, Li J, Yan M, Lin H, Liu Y, Chu D, Tu H, Gu A, Yao M.
    Oncotarget; 2015 Oct 06; 6(30):30239-50. PubMed ID: 26317552
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 06; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
    Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH.
    Clin Chim Acta; 2010 Jun 03; 411(11-12):846-52. PubMed ID: 20223231
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.
    Liu ZL, Wang H, Liu J, Wang ZX.
    Mol Cell Biochem; 2013 Jan 03; 372(1-2):35-45. PubMed ID: 22956424
    [Abstract] [Full Text] [Related]

  • 5. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.
    Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu FQ, Hu R, Wang MS.
    Int J Clin Exp Pathol; 2015 Jan 03; 8(4):3827-34. PubMed ID: 26097565
    [Abstract] [Full Text] [Related]

  • 6. MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.
    Li S, Ma Y, Hou X, Liu Y, Li K, Xu S, Wang J.
    Int J Clin Exp Pathol; 2015 Jan 03; 8(9):11854-62. PubMed ID: 26617940
    [Abstract] [Full Text] [Related]

  • 7. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
    Yang WB, Zhang WP, Shi JL, Wang JW.
    Eur Rev Med Pharmacol Sci; 2018 Jun 03; 22(11):3408-3414. PubMed ID: 29917192
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.
    Ren P, Gong F, Zhang Y, Jiang J, Zhang H.
    Tumour Biol; 2016 Mar 03; 37(3):3215-25. PubMed ID: 26432332
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ, Gao W, Lei WB, Zhao J, Chan JY, Wei WI, Ho WK, Wong TS.
    Oncotarget; 2016 Sep 06; 7(36):58218-58233. PubMed ID: 27533461
    [Abstract] [Full Text] [Related]

  • 10. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.
    Lei L, Huang Y, Gong W.
    Oncol Rep; 2013 Dec 06; 30(6):2897-902. PubMed ID: 24084898
    [Abstract] [Full Text] [Related]

  • 11. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH, Zhang CL, Dong FS, Zhang YM.
    J Cell Biochem; 2015 Feb 06; 116(2):268-76. PubMed ID: 25187230
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
    Zhu DY, Li XN, Qi Y, Liu DL, Yang Y, Zhao J, Zhang CY, Wu K, Zhao S.
    Biomed Pharmacother; 2016 Jul 06; 81():79-85. PubMed ID: 27261580
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.
    Ling C, Wang X, Zhu J, Tang H, Du W, Zeng Y, Sun L, Huang JA, Liu Z.
    Cancer Med; 2019 Jul 06; 8(7):3520-3531. PubMed ID: 31074594
    [Abstract] [Full Text] [Related]

  • 16. microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.
    Liu C, Yang H, Xu Z, Li D, Zhou M, Xiao K, Shi Z, Zhu L, Yang L, Zhou R.
    J Cancer Res Clin Oncol; 2015 Mar 06; 141(3):431-41. PubMed ID: 25245053
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. NF-κB-Induced Upregulation of miR-548as-3p Increases Invasion of NSCLC by Targeting PTEN.
    Akgun S, Kucuksayan H, Ozes ON, Can O, Alikanoglu AS, Yildiz M, Akca H.
    Anticancer Agents Med Chem; 2019 Mar 06; 19(8):1058-1068. PubMed ID: 30727918
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT.
    Xing S, Qu Y, Li C, Huang A, Tong S, Wu C, Fan K.
    J Cell Physiol; 2019 Dec 06; 234(12):22657-22665. PubMed ID: 31111480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.